The Potential of Minocycline for Neuroprotection in Human Neurologic Disease
Abstract
Minocycline is a member of the tetracycline class of molecules with broad-spectrum antibiotic activity. The unique properties of minocycline result in increased tissue distribution when compared with the other tetracyclines. Of particular interest is the ability of minocycline to diffuse into the central nervous system at clinically effective levels. Aside from its antimicrobial properties, minocycline has been found to have beneficial effects on inflammation, microglial activation, matrix metalloproteinases, nitric oxide production, and apoptotic cell death. Concordantly, minocycline has been found to have neuroprotective effects in animal models of a number of diseases including stroke, multiple sclerosis, and Parkinson disease. The proven safety of minocycline over decades of use as an antibiotic suggests that it may have potential for development into an effective treatment of multiple neurologic conditions in humans.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Minocycline efficiently crosses the BBB.
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [257]
Minocycline is considered neuroprotective for a variety of neurological conditions, including PD.
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [257]
Cites
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929 · see citing works
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559 · see citing works
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,071 · see citing works
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,056 · see citing works
Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040 · see citing works
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006 · see citing works
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · see citing works
Vasudeva, R., Tanga, F. Y., & DeLeo, J. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052407 · Cited by 797 · see citing works
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789 · see citing works
Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547 · see citing works
Tikka, T., & Koıstınaho, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 530 · see citing works
Stirling, D. P., Khodarahmi, K., Liu, J., McPhail, L. T., McBride, C. B., Steeves, J. D., Ramer, M. S., & Tetzlaff, W. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5275-03.2004 · Cited by 506 · see citing works
Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice.
Wells, J., Hurlbert, R., Fehlings, M., & Yong, W. V. (2003) · Brain : a journal of neurology · doi:10.1093/brain/awg178 · Cited by 437 · see citing works
Targeting leukocyte MMPs and transmigration
Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C. A., & Yong, V. W. (2002) · Brain · doi:10.1093/brain/awf133 · Cited by 427 · see citing works
Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis
Križ, J., Nguyen, M. D., & Julien, J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0487 · Cited by 411 · see citing works
Wang, X., Zhu, S., Drozda, M., Zhang, W., Stavrovskaya, I. G., Cattaneo, E. F., Ferrante, R. J., Kristal, B. S., & Friedlander, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832501100 · Cited by 407 · see citing works
Sanchez-Mejia, R., Ona, V., Li, M.-W., & Friedlander, R. (2001) · Neurosurgery · doi:10.1097/00006123-200106000-00051 · Cited by 373 · see citing works
Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases
Power, C., Henry, S. D., Bigio, M. R. D., Larsen, P. H., Corbett, D., Imai, Y., Yong, V. W., & Peeling, J. (2003) · Annals of Neurology · doi:10.1002/ana.10553 · Cited by 363 · see citing works
He, Y., Appel, S. H., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 350 · see citing works
Clinical Pharmacokinetics of Doxycycline and Minocycline
Saivin, S., & Houin, G. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815060-00001 · Cited by 350 · see citing works
Minocycline in Rheumatoid Arthritis: A 48-Week, Double-Blind, Placebo-Controlled Trial
Tilley, B. C., Alarcon, G. S., Heyse, S. P., Trentham, D. E., Neuner, R., Kaplan†, D. A., Clegg, D. O., Leisen, J. C. C., Buckley, L., Cooper, S. M., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-2-199501150-00001 · Cited by 339 · see citing works
Teng, Y. D., Choi, H., Onario, R. C., Zhu, S., Desilets, F. C., Lan, S., Woodard, E. J., Snyder, E. Y., Eichler, M. E., & Friedlander, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306239101 · Cited by 335 · see citing works
Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injury
Arvin, K. L., Han, B., Du, Y.-S., Lin, S.-Z., Paul, S. M., & Holtzman, D. (2002) · Annals of Neurology · doi:10.1002/ana.10242 · Cited by 323 · see citing works
Lee, S. M., Yune, T. Y., Kim, S. J., Park, D. W., Lee, Y. K., Kim, Y. C., Oh, Y. J., Markelonis, G. J., & Oh, T. H. (2003) · Journal of Neurotrauma · doi:10.1089/089771503770195867 · Cited by 305 · see citing works
Minocycline delays disease onset and mortality in a transgenic model of ALS
Bosch, L. V. D., Tilkin, P., Lemmens, G., & Robberecht, W. (2002) · Neuroreport · doi:10.1097/00001756-200206120-00018 · Cited by 297 · see citing works
Inhibition of autoimmune encephalomyelitis by a tetracycline
Popovic, N., Schubart, A., Goetz, B. D., Zhang, S., Linington, C., & Duncan, I. D. (2002) · Annals of Neurology · doi:10.1002/ana.10092 · Cited by 295 · see citing works
Dommergues, M.-A., Plaisant, F., Verney, C., & Gressèns, P. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00558-x · Cited by 221 · see citing works
Deleterious Effects of Minocycline in Animal Models of Parkinson’s Disease and Huntington’s Disease
Diguet, E., Fernagut, P., Wei, X., Du, Y., Rouland, R., Gross, C., Bezard, E., & Tison, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03372.x · Cited by 189 · see citing works
Klein, N. C., & Cunha, B. A. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30039-6 · Cited by 187 · see citing works
Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS
Zhang, W., Narayanan, M. V., & Friedlander, R. M. (2003) · Annals of Neurology · doi:10.1002/ana.10476 · Cited by 185 · see citing works
Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model
Tsuji, M., Wilson, M. A., Lange, M. S., & Johnston, M. V. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.011 · Cited by 181 · see citing works
Minocycline and doxycycline are not beneficial in a model of Huntington's disease
Smith, D. L., Woodman, B., Mahal, A., Sathasivam, K., Ghazi‐Noori, S., Lowden, P. A. S., Bates, G. P., & Hockly, E. (2003) · Annals of Neurology · doi:10.1002/ana.10614 · Cited by 173 · see citing works
Xu, L., Fagan, S. C., Waller, J. L., Edwards, D. J., Borlongan, C. V., Zheng, J., Hill, W., Feuerstein, G., & Hess, D. C. (2004) · BMC Neurology · doi:10.1186/1471-2377-4-7 · Cited by 172 · see citing works
Minocycline reduces gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis
Metz, L. M., Zhang, Y., Yeung, M., Patry, D. G., Bell, R. B., Stoian, C. A., Yong, V. W., Patten, S. B., Duquette, P., Antel, J. P., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20111 · Cited by 171 · see citing works
Mejia, R. O. S., Ona, V. O., Li, M., et al. (2001) · Neurosurgery · doi:10.1227/00006123-200106000-00051 · Cited by 171 · see citing works
Greenwald, R. A., Moak, S. A., Ramamurthy, N. S., & Golub, L. M. (1992) · PubMed · Cited by 164 · see citing works
Minocycline Enhances MPTP Toxicity to Dopaminergic Neurons
Yang, L., Sugama, S., Chirichigno, J. W., Gregorio, J., Lorenzl, S., Shin, D. H., Browne, S. E., Shimizu, Y., Joh, T. H., Beal, M. F., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10709 · Cited by 158 · see citing works
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis
Gordon, P. H., Moore, D. H., Gelinas, D. F., Qualls, C., Meister, M. E., Werner, J., Mendoza, M., Mass, J., Kushner, G., & Miller, R. G. (2004) · Neurology · doi:10.1212/01.wnl.0000125321.92112.7e · Cited by 139 · see citing works
Minocycline treatment and pseudotumor cerebri syndrome
Chiu, A. M., Chuenkongkaew, W. L., Cornblath, W. T., Trobe, J. D., Digre, K. B., Dotan, S., Musson, K. H., & Eggenberger, E. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(98)00063-4 · Cited by 137 · see citing works
Tikka, T., Vartiainen, N. E., Goldsteins, G., Oja, S. S., Andersen, P. M., Marklund, S. L., & Koıstınaho, J. (2002) · Brain · doi:10.1093/brain/awf068 · Cited by 136 · see citing works
Efficient three‐drug cocktail for disease induced by mutant superoxide dismutase
Križ, J., Gowing, G., & Julien, J. (2003) · Annals of Neurology · doi:10.1002/ana.10500 · Cited by 133 · see citing works
Scarabelli, T. M., Stephanou, A., Pasini, E., Gitti, G., Townsend, P. A., Lawrence, K. M., Chen-Scarabelli, C. A., Saravolatz, L. I. I., Latchman, D. S., Knight, R. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.050 · Cited by 127 · see citing works
Kremlev, S. G., Roberts, R. L., & Palmer, C. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.11.012 · Cited by 117 · see citing works
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection
Fagan, S. C., Edwards, D. J., Borlongan, C. V., Xu, L., Arora, A., Feuerstein, G., & Hess, D. C. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.12.006 · Cited by 117 · see citing works
Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Thomas, M., & Le, W. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453162 · Cited by 114 · cited 1× · see citing works
“Minocycline has been found to block the activation of microglia and protect against neurodegeneration in both the 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP) models of Parkinson disease.(48) Minocycline has been found to be protective in the MPTP model of Parkinson disease when…”
BackgroundMinocycline in Huntington's disease: A pilot study
Thomas, M., Ashizawa, T., & Jankovic, J. J. (2004) · Movement Disorders · doi:10.1002/mds.20018 · Cited by 111 · see citing works
Liver Damage Associated with Minocycline Use in Acne
Lawrenson, R. A., Seaman, H. E., m, A. S., Williams, T. J., & Farmer, R. D. T. (2000) · Drug Safety · doi:10.2165/00002018-200023040-00006 · Cited by 101 · see citing works
Gelatinase B/matrix metalloproteinase‐9 cleaves interferon‐β and is a target for immunotherapy
Nelissen, I., Martens, E., den Steen, P. E. V., Proost, P., Ronsse, I., & Opdenakker, G. (2003) · Brain · doi:10.1093/brain/awg129 · Cited by 100 · see citing works
Tikka, T., Usenius, T., Tenhunen, M., Keinänen, R., & Koistinaho, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00543.x · Cited by 96 · see citing works
RYAN, M. E., Usman, A., Ramamurthy, N. S., Golub, L. M., & Greenwald, R. A. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373598 · Cited by 96 · see citing works
Minocycline for Huntington’s disease: An open label study
Bonelli, R. M., Heuberger, C., & Reisecker, F. (2003) · Neurology · doi:10.1212/01.wnl.0000049936.85487.7a · Cited by 86 · see citing works
ALLEN, J. C. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-4-482 · Cited by 79 · see citing works
Lin, S., Wei, X., Xu, Y., Yan, C., Dodel, R., Zhang, Y., Liu, J., Klaunig, J. E., Farlow, M., & Du, Y. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02442-6 · Cited by 70 · see citing works
Minocycline protects basal forebrain cholinergic neurons from mu p75‐saporin immunotoxic lesioning
Hunter, C. L., Quintero, E. M., Gilstrap, L., Bhat, N. R., & Granholm, A. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03439.x · Cited by 63 · see citing works
Zhang, S., Goetz, B. D., & Duncan, I. D. (2002) · Glia · doi:10.1002/glia.10172 · Cited by 60 · see citing works
Delayed minocycline but not delayed mild hypothermia protects against embolic stroke
Wang, C. X., Yang, T., Noor, R., & Shuaib, A. M. (2002) · BMC Neurology · doi:10.1186/1471-2377-2-2 · Cited by 59 · see citing works
Vanderkerckhove, B. N. A., Quirynen, M., & van Steenberghe, D. (1998) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.1998.tb02399.x · Cited by 49 · see citing works
Zang, D. W., & Cheema, S. S. (2003) · Journal of Neurotrauma · doi:10.1089/089771503770802880 · Cited by 48 · see citing works
Side Effects of Minocycline: Different Dosage Regimens
Gump, D. W., Ashikaga, T., Fink, T. J., & Radin, A. M. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.5.642 · Cited by 42 · see citing works
Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease
Diguet, E., Rouland, R., & Tison, F. (2003) · Annals of Neurology · doi:10.1002/ana.10818 · Cited by 35 · see citing works
Pourtaghi, N., Radvar, M., Mooney, J. J., & Kinane, D. F. (1996) · Journal of Periodontology · doi:10.1902/jop.1996.67.9.866 · Cited by 31 · see citing works
Maintained improvement with minocycline of a patient with advanced Huntington's disease
Denovan‐Wright, E. M., Devarajan, S., Dursun, S. M., & Robertson, H. A. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600417 · Cited by 29 · see citing works
Treatment of Osteoporosis with MMP Inhibitors
WILLIAMS, S., Barnes, J., Wakisaka, A., Ogasa, H., & Liang, C. T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07684.x · Cited by 29 · see citing works
Freeman, K. (1989) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1989.tb08684.x · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.027 · Cited by 2,012 · see citing works
The neuropathic pain triad: neurons, immune cells and glia
Scholz, J., & Woolf, C. J. (2007) · Nature Neuroscience · doi:10.1038/nn1992 · Cited by 1,738 · see citing works
Minocycline: Far beyond an Antibiotic
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935 · see citing works
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.010 · Cited by 799 · see citing works
Microglia in the Retina: Roles in Development, Maturity, and Disease
Silverman, S. M., & Wong, W. T. (2018) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034425 · Cited by 351 · see citing works
The neuroimmune basis of fatigue
Dantzer, R., Heijnen, C. J., Kavelaars, A., Laye, S., & Capuron, L. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.10.003 · Cited by 346 · see citing works
Irritable bowel syndrome: A microbiome-gut-brain axis disorder?
Kennedy, P. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14105 · Cited by 335 · see citing works
Lee, S. M., Yune, T. Y., Kim, S. J., Park, D. W., Lee, Y. K., Kim, Y. C., Oh, Y. J., Markelonis, G. J., & Oh, T. H. (2003) · Journal of Neurotrauma · doi:10.1089/089771503770195867 · Cited by 305 · see citing works
MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke
Chaturvedi, M., & Kaczmarek, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8538-z · Cited by 296 · see citing works
Prospects for Minocycline Neuroprotection
Plane, J. M., Shen, Y., Pleasure, D., & Deng, W. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.191 · Cited by 276 · see citing works
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205 · see citing works
Machado, L. S., Kozak, A., Ergul, A., Hess, D. C., Borlongan, C. V., & Fagan, S. C. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-56 · Cited by 193 · see citing works
Critical data‐based re‐evaluation of minocycline as a putative specific microglia inhibitor
Möller, T., Bard, F., Bhattacharya, A., Biber, K. P. H., Campbell, B., Dale, E., Eder, C., Gan, L., Garden, G. A., Hughes, Z. A., et al. (2016) · Glia · doi:10.1002/glia.23007 · Cited by 192 · see citing works
TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
Zhao, C., Ling, Z., Newman, M. B., Bhatia, A., & Carvey, P. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.012 · Cited by 183 · see citing works
Hailer, N. P. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.001 · Cited by 181 · see citing works
Translational approaches to treatment-induced symptoms in cancer patients
Dantzer, R., Meagher, M. W., & Cleeland, C. S. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.88 · Cited by 161 · see citing works
Acute Minocycline Treatment Mitigates the Symptoms of Mild Blast-Induced Traumatic Brain Injury
Kövesdi, E., Kamnaksh, A., Wingo, D., Ahmed, F. A. K. M., Grunberg, N. E., Long, J. B., Kasper, C. E., & Agoston, D. V. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00111 · Cited by 160 · see citing works
What is behind the non-antibiotic properties of minocycline?
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.006 · Cited by 158 · see citing works
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
Matsukawa, N., Yasuhara, T., Hara, K., Xu, L., Maki, M., Yu, G., Kaneko, Y., Ojika, K., Hess, D. C., & Borlongan, C. V. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-126 · Cited by 146 · see citing works
Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia
Mena, M. A., & de Yébenes, J. G. (2008) · The Neuroscientist · doi:10.1177/1073858408322839 · Cited by 141 · see citing works
Neuroprotection in Stroke: Past, Present, and Future
Majid, A. (2014) · ISRN Neurology · doi:10.1155/2014/515716 · Cited by 138 · see citing works
Self-citationMicroglia and inflammation: Impact on developmental brain injuries
Chew, L., Takanohashi, A., & Bell, M. J. (2006) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20102 · Cited by 134 · see citing works
Croisier, E., & Graeber, M. B. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0119-z · Cited by 130 · see citing works
NADPH oxidase is involved in post-ischemic brain inflammation
Chen, H., Kim, G. S., Okami, N., Narasimhan, P., & Chan, P. H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.027 · Cited by 116 · see citing works
Cukras, C. A., Petrou, P. A., Chew, E. Y., MEYERLE, C. B., & Wong, W. T. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9413 · Cited by 107 · see citing works
Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
Uchoa, M. F., Moser, V., & Pike, C. J. (2016) · Frontiers in neuroendocrinology (Print) · doi:10.1016/j.yfrne.2016.09.001 · Cited by 95 · see citing works
The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development
Zera, K. A., & Buckwalter, M. S. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00844-3 · Cited by 102 · see citing works
Inta, D., Lang, U. E., Borgwardt, S., Meyer‐Lindenberg, A., & Gass, P. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw088 · Cited by 98 · see citing works
Modulating Inflammatory Cell Responses to Spinal Cord Injury: All in Good Time
Bowes, A. L., & Yip, P. K. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3429 · Cited by 98 · see citing works
Rojewska, E., Popiołek-Barczyk, K., Jurga, A. M., Makuch, W., Przewłocka, B., & Mika, J. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.09.020 · Cited by 92 · see citing works
Zhu, X., Hu, J., Deng, S., Tan, Y., Qiu, C., Zhang, M., Ni, X., Lu, H., Wang, Z., Li, L., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587670 · Cited by 92 · see citing works
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88 · see citing works
McCarty, M. F. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.013 · Cited by 87 · see citing works
Role of spinal cord glia in the central processing of peripheral pain perception
Bradesi, S. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01491.x · Cited by 85 · see citing works
Minocycline inhibits the growth of glioma by inducing autophagy
Liu, W., Lin, C.-H., Hsiao, M., & Gean, P. (2011) · Autophagy · doi:10.4161/auto.7.2.14043 · Cited by 78 · see citing works
Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion
Cho, K., La, H. O., Cho, Y., Sung, K.-W., & Kim, S.-Y. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20727 · Cited by 78 · see citing works
Strategies to Promote Neural Repair and Regeneration After Spinal Cord Injury
Kwon, B. K., Fisher, C. G., Dvorak, M. F., & Tetzlaff, W. (2005) · Spine · doi:10.1097/01.brs.0000175186.17923.87 · Cited by 77 · see citing works
Żychowska, M., Rojewska, E., Makuch, W., Luvisetto, S., Pavone, F., Marinelli, S., Przewłocka, B., & Mika, J. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.019 · Cited by 75 · see citing works
Hewlett, K. A., & Corbett, D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.071 · Cited by 74 · see citing works
Savitz, J. B., Preskorn, S., Teague, T. K., Drevets, D. A., Yates, W. R., & Drevets, W. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000643 · Cited by 72 · see citing works
Improving Outcomes of Neuroprotection by Minocycline
Xue, M., Mikliaeva, E. I., Casha, S., Zygun, D., Demchuk, A. M., & Yong, V. W. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090361 · Cited by 71 · see citing works
Bradesi, S., Svensson, C. I., Steinauer, J., Pothoulakis, C., Yaksh, T. L., & Mayer, E. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.044 · Cited by 69 · see citing works
Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies
Mastroianni, C. M., & Liuzzi, G. M. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.001 · Cited by 68 · see citing works
Microglia and the control of autoreactive T cell responses
Melchior, B., Puntambekar, S. S., & Carson, M. J. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.04.002 · Cited by 67 · see citing works
Jin, Z., Liang, J., Wang, J., & Kolattukudy, P. E. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0264-1 · Cited by 66 · see citing works
Cavaliere, F., Dinkel, K., & Reymann, K. G. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.038 · Cited by 64 · see citing works
Lechpammer, M., Manning, S. M., Samonte, F., Nelligan, J., Sabo, E., Talos, D. M., Volpe, J. J., & Jensen, F. E. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00925.x · Cited by 63 · see citing works
An update on pharmacological approaches to neurodegenerative diseases
Scatena, R., Martorana, G. E., Bottoni, P., Botta, G., Pastore, P., & Giardina, B. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.59 · Cited by 60 · see citing works
Shankaran, M., Marino, M. E., Busch, R., Keim, C., King, C. L., Lee, J. Y. H., Killion, S., Awada, M., & Hellerstein, M. K. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21389 · Cited by 58 · see citing works
Anxiety After Cardiac Arrest/Cardiopulmonary Resuscitation
Neigh, G. N., Karelina, K., Glasper, E. R., Bowers, S., Zhang, N., Popovich, P. G., & DeVries, A. C. (2009) · Stroke · doi:10.1161/strokeaha.109.564146 · Cited by 56 · see citing works
Ratai, E., Bombardier, J. P., Joo, C., Annamalai, L., Burdo, T. H., Campbell, J. H., Fell, R., Hakimelahi, R., He, J., Autissier, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010523 · Cited by 56 · see citing works
Hernandes, M. S., Santos, G. D. R., Café-Mendes, C. C., Lima, L. S., Scavone, C., Munhoz, C. D., & Britto, L. R. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075532 · Cited by 54 · see citing works
Zang, D. W., & Cheema, S. S. (2003) · Journal of Neurotrauma · doi:10.1089/089771503770802880 · Cited by 48 · see citing works
Liu, H., Kim, Y., Chattopadhyay, S., Shubayev, I., Dolkas, J., & Shubayev, V. I. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d68d12 · Cited by 47 · see citing works
Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
Mitchell, R. M., Lee, S. Y., Randazzo, W. T., Simmons, Z., & Connor, J. R. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-6 · Cited by 46 · see citing works
Defaux, A., Zurich, M.-G., Honegger, P., & Monnet-Tschudi, F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.053 · Cited by 40 · see citing works
The effect of stroke on immune function
Brambilla, R., Couch, Y., & Lambertsen, K. L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.011 · Cited by 38 · see citing works
Cho, K., Kim, S.-K., Cho, Y., Sung, K.-W., & Kim, S.-Y. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.03.005 · Cited by 40 · see citing works
Minocycline Blocks Acute Bilirubin-Induced Neurological Dysfunction in Jaundiced Gunn Rats
Geiger, A. S., Rice, A. C., & Shapiro, S. M. (2007) · Neonatology · doi:10.1159/000103740 · Cited by 40 · see citing works
Hypoxic Ischemic Encephalopathy—What Can We Learn from Humans?
Dickey, E. J., Long, S., & Hunt, R. W. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2011.00818.x · Cited by 39 · see citing works
Evidence of Central and Peripheral Sensitization in a Rat Model of Narcotic Bowel-Like Syndrome
Agostini, S., Eutamène, H., Cartier, C., Broccardo, M., Improta, G., Houdeau, É., Petrella, C., Ferrier, L., Theodorou, V., & Bueno, L. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.046 · Cited by 38 · see citing works
Sturchio, A., Marsili, L., Vizcarra, J. A., Dwivedi, A. K., Kauffman, M. A., Duker, A. P., Lu, P., Pauciulo, M. W., Wissel, B. D., Hill, E. J., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.553635 · Cited by 39 · see citing works
Vascular Protection in Brain Ischemia
Rodríguez‐Yáñez, M., Castellanos, M., Blanco, M., Mosquera, E., & Castillo, J. (2006) · Cerebrovascular Diseases · doi:10.1159/000091700 · Cited by 36 · see citing works
Inhibiting effect of minocycline on the regeneration of peripheral nerves
Keilhoff, G., Langnaese, K., Wolf, G. L., & Fansa, H. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20384 · Cited by 35 · see citing works
Guillot, X., Semerano, L., Decker, P., Falgarone, G., & Boissier, M. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.10.008 · Cited by 33 · see citing works
Liu, Z., Liang, Y., Wang, H., Lu, Z., Chen, J., Huang, Q., Sheng, L., Ma, Y., Du, H., & Gong, Q. (2017) · Journal of Pain Research · doi:10.2147/jpr.s147055 · Cited by 32 · see citing works
Prevention of hypoglycemia-induced neuronal death by minocycline
Won, S. J., Kim, J. H., Yoo, B. H., Sohn, M., Kauppinen, T. M., Park, M.-S., Kwon, H., Liu, J., & Suh, S. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-225 · Cited by 32 · see citing works
Zhang, Z., Zhang, Z., Fauser, U., & Schluesener, H. J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00333.x · Cited by 31 · see citing works
Gold, J. R. (2015) · Equine Veterinary Education · doi:10.1111/eve.12467 · Cited by 28 · see citing works
Lima‐Silveira, L., Accorsi‐Mendonça, D., Bonagamba, L. G. H., Almado, C. E. L., da Silva, M. P., Nedoboy, P. E., Pilowsky, P. M., & Machado, B. H. (2019) · The Journal of Physiology · doi:10.1113/jp277532 · Cited by 28 · see citing works
Enose‐Akahata, Y., Matsuura, E., Tanaka, Y., Oh, U., & Jacobson, S. (2012) · Retrovirology · doi:10.1186/1742-4690-9-16 · Cited by 28 · see citing works
Paizs, M., Engelhardt, J. I., & Siklós, L. (2009) · Journal of Microscopy · doi:10.1111/j.1365-2818.2009.03146.x · Cited by 26 · see citing works
Hyperthyroidism and Lupus‐like Syndrome in an Adolescent Treated with Minocycline for Acne Vulgaris
Benjamin, R. W., & Calikoglu, A. S. (2007) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2007.00395.x · Cited by 26 · see citing works
Visceral Pain and Psychiatric Disorders
Felice, V. D., Moloney, R. D., Cryan, J. F., Dinan, T. G., & O’Mahony, S. M. (2015) · Modern trends in psychiatry · doi:10.1159/000435936 · Cited by 25 · see citing works
Repurposing of pexidartinib for microglia depletion and renewal
Weyer, M.-P., Strehle, J., Schäfer, M. K. E., & Tegeder, I. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108565 · Cited by 23 · see citing works
Protection of Minocycline on Early Brain Injury After Subarachnoid Hemorrhage in Rats
Guo, Z., Wu, H., Sun, X., Zhang, X., & Zhang, J. H. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0353-1_13 · Cited by 22 · see citing works
Neuroprotection for Parkinson’s disease
LeWitt, P. A. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_13 · Cited by 20 · see citing works
Antibiotics acting as neuroprotectants via mechanisms independent of their anti-infective activities
Stock, M. L., Fiedler, K. J., Acharya, S., Lange, J. K., Mlynarczyk, G. S. A., Anderson, S. J., Schmidt-McCormack, G. R., Kanuri, S. H., Kondru, N. C., Brewer, M. T., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.059 · Cited by 19 · see citing works
Emerging drugs for Parkinson’s disease
Morgan, J. C., & Sethi, K. D. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.3.403 · Cited by 19 · see citing works
Zhang, Z., Zhang, Z., Fauser, U., & Schluesener, H. J. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00172.x · Cited by 18 · see citing works
Schwartz, M., Butovsky, O., & Kipnis, J. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-005-9010-2 · Cited by 17 · see citing works
Plasticity of microglia in remote regions after focal brain injury
Bisicchia, E., Sasso, V., Molinari, M., & Viscomi, M. T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.01.011 · Cited by 17 · see citing works
Dragun, P., Makarewicz, D., Wójcik, L., Ziemka‐Nałęcz, M., Słomka, M., & Zalewska, T. (2008) · PubMed · Cited by 17 · see citing works
Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy
Luo, M., Liu, H., Hu, S., & Bai, F. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.06.020 · Cited by 15 · see citing works
Neuroprotective effect of minocycline on rat retinal ischemia-reperfusion injury.
Li, X., Ye, Z., Pei, S., Zheng, D., & Zhu, L. (2021) · PubMed Central · Cited by 15 · see citing works
Minocycline Attenuates Ototoxicity and Enhances Antitumor Activity of Cisplatin Treatment In Vitro
Du, B., Zhang, Y., Tang, Y., & Wang, P. (2011) · Otolaryngology · doi:10.1177/0194599810395090 · Cited by 14 · see citing works
Social interaction modulates the neuroinflammatory response to global cerebral ischemia in male mice
Gaudier‐Diaz, M. M., Zhang, N., Haines, A. H., Surbhi, Zhou, M., & DeVries, A. C. (2017) · Brain Research · doi:10.1016/j.brainres.2017.08.008 · Cited by 13 · see citing works
Potter, E. G., Cheng, Y., & Natale, J. E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21963 · Cited by 11 · see citing works
Shochat, A., & Abookasis, D. (2015) · Neurophotonics · doi:10.1117/1.nph.2.1.015001 · Cited by 10 · see citing works
Li, S., Yang, F., Ji, P., Zeng, X., Wu, X., Wei, J., OuYang, L., Liang, J., Zheng, H., Wu, Z., et al. (2013) · Parasitology Research · doi:10.1007/s00436-013-3683-x · Cited by 9 · see citing works
Potential therapeutic agents for ischemic white matter damage
Youssef, M. I., Ma, J., Chen, Z., & Hu, W. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105116 · Cited by 8 · see citing works
Wu, W. E., Tal, A., Kirov, I. I., Rusinek, H., Charytonowicz, D., Babb, J. S., Ratai, E., González, R., & Gonen, O. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2889 · Cited by 8 · see citing works
Minocycline inhibits peritoneal macrophages but activates alveolar macrophages in acute pancreatitis
Bonjoch, L., Gea‐Sorlí, S., Jordán, J., & Closa, D. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0448-2 · Cited by 8 · see citing works
The Importance of Glia in Dealing with Stress
Woodbury-Fariña, M. A. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.08.003 · Cited by 7 · see citing works
Grochecki, P., Smaga, I., Marszałek‐Grabska, M., Łopatyńska-Mazurek, M., Słowik, T., Gibuła‐Tarłowska, E., Kędzierska, E., Listos, J., Filip, M., & Kotlinska, J. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042122 · Cited by 6 · see citing works
Protective Effect of Minocycline Treatment on Striatal Ischemia
Peeling, J., Yan, H.-J., Buist, R. J., SITAR, D. S., & Corbett, D. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2006.03.001 · Cited by 6 · see citing works
Raghib, M. F., & Bernitsas, E. (2023) · Biomedicines · doi:10.3390/biomedicines11113069 · Cited by 5 · see citing works
Tetracycline delays ocular motility decline in chronic progressive external ophthalmoplegia
Omar, A., & Johnson, L. N. (2007) · Neurology · doi:10.1212/01.wnl.0000258659.21421.b0 · Cited by 5 · see citing works
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50018-8 · Cited by 5 · see citing works
The Neuroinflammation in the Physiopathology of Amyotrophic Lateral Sclerosis
Bowerman, M., Vincent, T., Scamps, F., Camu, W., & Raoul, C. (2013) · InTech eBooks · doi:10.5772/56489 · Cited by 5 · see citing works
- Authors
- Zemke, D., & Majid, A.
- Affiliations
- Michigan State University (US)
- ORCID
- Majid, Arshad
- Venue
- Clinical Neuropharmacology
- Published
- 2004-11
- Volume
- 27
- Issue
- 6
- Pages
- 293-298
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W2047780499
- Cited by
- 125
- References
- 64
- Citations by year
- 2026: 2 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 7 · 2016: 7 · 2015: 6 · 2014: 8 · 2013: 9 · 2012: 10
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- minocycline, neuroprotection, tetracycline, CNS penetration, neuroinflammation, microglial activation, matrix metalloproteinases, nitric oxide, apoptosis, stroke, multiple sclerosis, Parkinson's disease, neurological disorders
- MeSH terms
- Animals, Humans, Minocycline, Nervous System Diseases, Cell Death, Microglia, Neuroprotective Agents, Matrix Metalloproteinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review